Lineage Cell Therapeutics Inc.
LCTX | AMEX
$1.01
$0 (0.00%)
Sep 22, 2026, 9:55 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.08M | 14.78M | 14.56M | 10.82M | 10.91M | 9.56M | 9.5M | 8.72M | 6.19M | 8M | 8.95M | 8.77M | 10.52M | 11.85M | 14.7M | 13.75M | 12.95M | 8.84M | 3.9M | 3.1M | 1.24M | 900K |
Cost of Revenue | 259K | 298K | 146K | 234K | 267K | 272K | 509K | 786K | 917K | 1M | 846K | 517K | 583K | 671K | 728K | 830K | 1.58M | 1.49M | 1.43M | 1.34M | 453K | 403K |
Gross Profit | 12.82M | 14.48M | 14.41M | 10.58M | 10.65M | 9.29M | 8.99M | 7.93M | 5.27M | 7M | 8.1M | 8.26M | 9.94M | 11.18M | 13.98M | 12.92M | 11.37M | 7.35M | 2.47M | 1.77M | 789K | 497K |
Operating Income | -26.85M | -37.71M | -36.62M | -35.18M | -35.24M | -21.32M | -21.48M | -22.73M | -25.6M | -24.75M | -24.73M | -25.01M | -23.56M | -22.77M | -22.52M | -44.12M | -45.71M | -48.56M | -49.21M | -26.86M | -26.74M | -26.06M |
Interest Income | 1.54M | 1.62M | 1.69M | 1.69M | 1.72M | 1.73M | 1.72M | 1.73M | 1.76M | 1.68M | 1.63M | 1.62M | 1.57M | 1.24M | 830K | 439K | 56K | 5K | 6K | 5K | 256K | 636K |
Pretax Income | -37.39M | -69.29M | -68.65M | -67.51M | -40.76M | -16.17M | -18.58M | -20.05M | -24.2M | -23.63M | -23.28M | -24.93M | -23.35M | -24.93M | -25.81M | -47.46M | -50.73M | -48.91M | -43.27M | -14.28M | -13.38M | -14.94M |
Net Income | -32.26M | -64.21M | -63.53M | -67.66M | -40.91M | -16.21M | -18.61M | -20.11M | -24.19M | -23.66M | -21.49M | -23.07M | -22.02M | -23.56M | -26.27M | -48.91M | -50.66M | -48.69M | -43.02M | -12M | -11.93M | -13.67M |
Selling & General & Admin | 19.35M | 18.69M | 18.46M | 18.01M | 18.23M | 18.03M | 18.02M | 17.76M | 17.39M | 17.28M | 17.16M | 17.36M | 17.74M | 18.76M | 22.51M | 22.59M | 23.48M | 22.75M | 18.21M | 17.3M | 15.62M | 14.99M |
Research & Development | 20.52M | 18.85M | 17.73M | 12.91M | 12.81M | 12.58M | 12.45M | 12.9M | 13.47M | 14.48M | 15.67M | 15.9M | 15.75M | 15.18M | 13.99M | 34.66M | 33.88M | 33.51M | 33.91M | 11.74M | 12.5M | 12.37M |
Other Expenses | -188K | 14.65M | 14.84M | 14.84M | 14.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -208K | -276K | -347K | -445K | -426K | -587K | -803K |
Operating Expenses | 39.67M | 52.19M | 51.03M | 45.76M | 45.88M | 30.61M | 30.47M | 30.66M | 30.86M | 31.76M | 32.83M | 33.27M | 33.5M | 33.95M | 36.5M | 57.04M | 57.08M | 55.91M | 51.68M | 28.62M | 27.53M | 26.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 3K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -153K | -296K | -296K | -296K | -143K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.93M | 52.49M | 51.18M | 46M | 46.15M | 30.88M | 30.98M | 31.45M | 31.78M | 32.76M | 33.68M | 33.78M | 34.08M | 34.62M | 37.22M | 57.87M | 58.66M | 57.4M | 53.11M | 29.96M | 27.98M | 26.96M |
Income Tax Expense | -5.28M | -5.28M | -5.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.8M | -1.8M | -1.26M | -1.26M | 541K | 1.72M | 169K | n/a | n/a | -2.24M | -1.41M | -1.24M |
Shares Outstanding (Basic) | 249.5M | 245.03M | 230.12M | 228.85M | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.08M | 169.65M | 167.62M | 167.62M | 159.6M | 158.73M |
Shares Outstanding (Diluted) | 261.47M | 261.18M | 230.12M | 228.85M | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.73M | 169.65M | 167.62M | 167.62M | 162.91M | 158.73M |
EPS (Basic) | -0.14 | -0.28 | -0.27 | -0.29 | -0.18 | -0.08 | -0.10 | -0.11 | -0.13 | -0.13 | -0.12 | -0.14 | -0.13 | -0.16 | -0.18 | -0.31 | -0.32 | -0.30 | -0.26 | -0.07 | -0.08 | -0.09 |
EPS (Diluted) | -0.18 | -0.28 | -0.27 | -0.29 | -0.18 | -0.08 | -0.10 | -0.11 | -0.13 | -0.13 | -0.12 | -0.14 | -0.13 | -0.16 | -0.18 | -0.31 | -0.32 | -0.29 | -0.25 | -0.07 | -0.08 | -0.09 |
EBITDA | -36.83M | -43.15M | -42.52M | -41.42M | -14.71M | -15.57M | -17.97M | -19.41M | -23.54M | -22.94M | -22.59M | -24.24M | -22.64M | -24.21M | -25.09M | -46.71M | -49.98M | -48.15M | -47.99M | -25.72M | -23.35M | -24.44M |
EBIT | -37.39M | -43.87M | -43.22M | -42.09M | -15.33M | -16.17M | -18.58M | -20.05M | -24.2M | -23.63M | -23.28M | -24.93M | -23.35M | -24.93M | -25.81M | -47.46M | -50.73M | -48.91M | -48.87M | -26.74M | -24.62M | -26.06M |
Depreciation & Amortization | 552K | 723K | 699K | 664K | 627K | 598K | 609K | 633K | 668K | 696K | 692K | 690K | 707K | 720K | 727K | 745K | 751K | 765K | 873K | 1.02M | 1.27M | 1.62M |
Add to Watchlist
Select watchlists to add or remove LCTX